JAK2-V617F–triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation
Blood (2009) 113 (8): 1866–1868.
Currently there are no citedby results. Try again later.
